These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17068248)

  • 1. Biomedicine. Avoiding collateral damage in Alzheimer's disease treatment.
    Glabe C
    Science; 2006 Oct; 314(5799):602-3. PubMed ID: 17068248
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of peripheral nerve myelination by the beta-secretase BACE1.
    Willem M; Garratt AN; Novak B; Citron M; Kaufmann S; Rittger A; DeStrooper B; Saftig P; Birchmeier C; Haass C
    Science; 2006 Oct; 314(5799):664-6. PubMed ID: 16990514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer disease: BACE1 branches out.
    Schubert C
    Nat Med; 2006 Oct; 12(10):1123. PubMed ID: 17024203
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inflammatory drug prospect.
    De Strooper B; König G
    Nature; 2001 Nov; 414(6860):159-60. PubMed ID: 11700538
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secretases as therapeutic targets for the treatment of Alzheimer's disease].
    Dejaegere T; de Strooper B
    Verh K Acad Geneeskd Belg; 2004; 66(1):29-58; discussion 58-9. PubMed ID: 15074081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease. Bad for the heart, bad for the mind?
    Marx J
    Science; 2001 Oct; 294(5542):508-9. PubMed ID: 11641483
    [No Abstract]   [Full Text] [Related]  

  • 8. [Secretases as targets for the treatment of Alzheimer's disease].
    Luo HM; Gu F
    Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):189-92. PubMed ID: 12889164
    [No Abstract]   [Full Text] [Related]  

  • 9. Alzheimer's disease. A firm base for drug development.
    De Strooper B; König G
    Nature; 1999 Dec; 402(6761):471-2. PubMed ID: 10591201
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific enzyme identified that snips APP into beta-amyloid.
    Senior K
    Drug Discov Today; 2005 Nov; 10(21):1408. PubMed ID: 16243255
    [No Abstract]   [Full Text] [Related]  

  • 11. Inclusion-body myositis and Alzheimer disease: two sides of the same coin, or different currencies altogether?
    Murphy MP; Golde TE
    Neurology; 2006 Jan; 66(2 Suppl 1):S65-8. PubMed ID: 16432148
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF; Martone R; Porte A
    J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice.
    Philipson O; Lannfelt L; Nilsson LN
    FEBS Lett; 2009 Sep; 583(18):3021-6. PubMed ID: 19683527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing pain, killing neurons?
    Wyss-Coray T
    Nat Med; 2005 May; 11(5):472-3. PubMed ID: 15875048
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saving the mind faces high hurdles.
    Travis J
    Science; 2005 Jul; 309(5735):731. PubMed ID: 16051787
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Alzheimer's disease].
    Ishiura S; Hattori C
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(14):2179-85. PubMed ID: 15559301
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
    Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
    Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACE1 in central nervous system myelination revisited.
    Treiber H; Hagemeyer N; Ehrenreich H; Simons M
    Mol Psychiatry; 2012 Mar; 17(3):237-9. PubMed ID: 22042227
    [No Abstract]   [Full Text] [Related]  

  • 20. 3-Substituted gem-cyclohexane sulfone based gamma-secretase inhibitors for Alzheimer's disease: conformational analysis and biological activity.
    Jelley RA; Elliott J; Gibson KR; Harrison T; Beher D; Clarke EE; Lewis HD; Shearman M; Wrigley JD
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3839-42. PubMed ID: 16682202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.